Navigation Links
Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus

ST. LOUIS, Dec. 17, 2010 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX), today announced plans to build a 227,000-square-foot structure in the NorthPark development area — the third office building and fourth facility at its headquarters campus in North St. Louis County.


The company also announced results from a recent independent study that found Express Scripts generates about $1 billion in economic benefits for Missouri each year. Edward C. Lawrence, Ph.D., finance professor at the University of Missouri–St. Louis College of Business, conducted the study.

"As the report shows, Express Scripts provides significant financial benefit to Missouri ― nearly $1 billion in 2010 ― and is poised to continue these high-value contributions to the state over the next decade," Dr. Lawrence said. "The expansion of its headquarters is another step in the mutually beneficial partnership between the company and the state."

The academically rigorous analysis of company data shows that Express Scripts generated more than $986 million in economic contribution to St. Louis and Missouri in 2010. This includes:

  • $902 million in spending by the company, its suppliers and related parties
  • 3,858 jobs at the company, with an additional 2,048 created indirectly
  • $59 million in new capital expenditures
  • $25.5 million in taxes

  • In addition, conservative projections for spending and growth indicate that the company will produce $10.5 billion in economic benefits over the next decade for the St. Louis metropolitan area and state of Missouri.

    The site of the new facility is near the Express Scripts Technology & Innovation Center, which formally opened in June, and its two headquarters buildings on the campus of the University of Missouri–St. Louis.

    The initiative, projected to cost in excess of $70 million, will bring together functions now performed at several sites in the Riverport area of Maryland Heights. Approximately 1,500 Express Scripts employees will move into the new facility upon completion, and the company will create 150 jobs in the area within two years of opening the building.

    George Paz, chairman, president and chief executive officer of Express Scripts, said: "By increasing our operational efficiencies, development of this new site advances Express Scripts' mission of making the use of prescription drugs safer and more affordable. It also continues our commitment to attracting a high-quality, diverse workforce from the St. Louis metropolitan area."

    Groundwork has started for the project. Pending necessary approvals and permits, the scheduled completion is the fourth quarter of 2011.

    "Express Scripts appreciates the efforts of Governor Jay Nixon and County Executive Charlie Dooley and their staffs, as well as our development partners, in helping to help make this happen," Paz said. "We are increasingly happy to call the St. Louis region our home and proud of the economic benefits our growth has contributed to the state and the county."

    The economic impact study is available at

    About Express ScriptsExpress Scripts, Inc., one of the largest pharmacy benefit management companies in North America, is leading the way toward creating better health and value for patients through Consumerology®, the advanced application of the behavioral sciences to healthcare. This approach is helping millions of members realize greater healthcare outcomes and lowering cost by assisting in influencing their behavior. Headquartered in St. Louis, Express Scripts provides integrated PBM services including network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. More information can be found at and Media Contact: Thom Gross314.684.6321 or

    SOURCE Express Scripts, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Express Scripts Establishes Industrys Most Comprehensive Specialty Benefits Organization; Enhances Patient Care and Guarantees Cost Savings
    2. Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance
    3. Express Scripts to Present at Investor Conferences in November
    4. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
    5. NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, The Directors Common Fund to Provide Human Tissue for GTEx, the New Genotype-Tissue Expression Project
    6. Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call
    7. Express Scripts Accurately Predicts Which Patients Are Likely to Ignore Doctors Orders
    8. Express Scripts Completes Spinoff of Rx Outreach
    9. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
    10. Express Scripts to Present at Barclays 2010 Global Healthcare Conference
    11. Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
    Post Your Comments:
    (Date:12/1/2015)... Sweden , December 1, 2015 ... Cancer Study Group (IBCSG, Bern ) and ... to be part of a state of the art trial, ... --> --> The study, ... treated with anti-hormonal therapy in combination with palbociclib, a cancer ...
    (Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 ... through its wholly-owned UK subsidiary Proximagen Ltd., today announced ... novel, oral small molecule inhibitor of Vascular Adhesion Protein ... in the treatment of inflammatory disease. The VAP-1 inhibitor ... --> --> Under the terms ...
    (Date:11/30/2015)... Asia,s largest exhibition and conference dedicated to the Medical Device ... 22 nd April 2016. --> --> ... --> -->   --> --> ... population and the government back up, the Medical Device is one of the ... . With the aging population and the government back up, the Medical ...
    Breaking Medicine Technology:
    (Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator ... the latest addition to the devices for sale in the United States. Clarity ... and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to ...
    (Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... has selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s ... including CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica ...
    (Date:12/1/2015)... ... 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has ... The order will be from the China Disabled Persons’ Federation, a central government association, ... solution for children and adults suffering from severe and profound hearing loss . ...
    (Date:12/1/2015)... ... December 01, 2015 , ... Tympani Inc., announced ... (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled the training ... solutions targeted to the high-end enterprise contact center marketplace. , Ed Kapelinski, President ...
    (Date:11/30/2015)... , ... November 30, 2015 , ... Trevor and Taylor ... as they play for the chance to represent the United States. This hybrid ... to be a part of their journey in addition to offering corporate sponsors with ...
    Breaking Medicine News(10 mins):